Daniel Pablo‐Marcos

605 total citations
11 papers, 28 citations indexed

About

Daniel Pablo‐Marcos is a scholar working on Infectious Diseases, Molecular Medicine and Molecular Biology. According to data from OpenAlex, Daniel Pablo‐Marcos has authored 11 papers receiving a total of 28 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Medicine and 3 papers in Molecular Biology. Recurrent topics in Daniel Pablo‐Marcos's work include Antibiotic Resistance in Bacteria (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and CRISPR and Genetic Engineering (3 papers). Daniel Pablo‐Marcos is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and CRISPR and Genetic Engineering (3 papers). Daniel Pablo‐Marcos collaborates with scholars based in Spain. Daniel Pablo‐Marcos's co-authors include Sergio García‐Fernández, Jorge Calvo, Pablo A. Fraile-Ribot, Marta Hernández-García, Laura Fernández-García, Javier Fernández, María López, Lucía Blasco, Belén Aracil and Felipe Fernández-Cuenca and has published in prestigious journals such as Frontiers in Microbiology, International Journal of Antimicrobial Agents and ACS Omega.

In The Last Decade

Daniel Pablo‐Marcos

8 papers receiving 28 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Pablo‐Marcos Spain	3	16	12	8	7	4	11	28
David Dreifuss Switzerland	4	11 0.7×	15 1.3×	4 0.5×	29 4.1×	5 1.3×	5	44
Ryan Hope Belgium	2	24 1.5×	3 0.3×	5 0.6×	4 0.6×	3 0.8×	2	40
Amanda de la Fuente Spain	4	10 0.6×	10 0.8×	2 0.3×	10 1.4×	14 3.5×	6	41
Neil Cunningham United Kingdom	4	7 0.4×	3 0.3×	2 0.3×	7 1.0×	7 1.8×	8	34
Jesús Agüero Balbín Spain	4	10 0.6×	2 0.2×	4 0.5×	4 0.6×	6 1.5×	6	24
Ane Sorarrain Spain	3	10 0.6×	11 0.9×	1 0.1×	9 1.3×	6 1.5×	5	20
Julie T. S. Chu Singapore	2	8 0.5×	11 0.9×		7 1.0×	7 1.8×	2	19
Christine Surrette United States	4	10 0.6×	27 2.3×	7 0.9×	3 0.4×	2 0.5×	7	47
Giselle D’Souza United Kingdom	2	20 1.3×	13 1.1×	1 0.1×	8 1.1×	3 0.8×	2	33
Jincun Zhao China	3	19 1.2×	7 0.6×		14 2.0×	2 0.5×	8	33

Countries citing papers authored by Daniel Pablo‐Marcos

Since Specialization

Citations

This map shows the geographic impact of Daniel Pablo‐Marcos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Pablo‐Marcos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Pablo‐Marcos more than expected).

Fields of papers citing papers by Daniel Pablo‐Marcos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Pablo‐Marcos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Pablo‐Marcos. The network helps show where Daniel Pablo‐Marcos may publish in the future.

Co-authorship network of co-authors of Daniel Pablo‐Marcos

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Pablo‐Marcos. A scholar is included among the top collaborators of Daniel Pablo‐Marcos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Pablo‐Marcos. Daniel Pablo‐Marcos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Pablo‐Marcos, Daniel, Olga Pacios, Sergio García‐Fernández, et al.. (2025). An accurate amplification-free CRISPR/Cas12a-based assay for GES β-lactamase detection. International Journal of Antimicrobial Agents. 66(1). 107506–107506.

Blasco, Lucía, Daniel Pablo‐Marcos, Inés Bleriot, et al.. (2025). The LAMP-CRISPR-Cas13a technique for detecting the CBASS mechanism of phage resistance in bacteria. Frontiers in Microbiology. 16. 1550534–1550534. 4 indexed citations

Ruiz, Raúl, Daniel Pablo‐Marcos, Mónica Gozalo, et al.. (2024). Rapid and Accurate Detection of the SARS-CoV-2 Omicron Variant with a CRISPR-Cas12a Reaction in the RT-qPCR Pot. ACS Omega. 9(16). 18046–18050. 2 indexed citations

García‐Fernández, Sergio, Zaira Moure, Daniel Pablo‐Marcos, et al.. (2024). Within-host transition to GES-55 during a GES-6-producing Serratia marcescens outbreak: Emergence of ceftazidime-avibactam resistance and increased susceptibility to carbapenems. International Journal of Antimicrobial Agents. 64(2). 107257–107257. 2 indexed citations

Moure, Zaira, et al.. (2023). Establishing a molecular laboratory in COVID-19 pandemic: The experience of a regional laboratory in Spain. Acta Microbiologica et Immunologica Hungarica. 70(1). 7–10.

Pablo‐Marcos, Daniel, Laura Fernández-García, Lucía Blasco, et al.. (2023). CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases. Microbiology Spectrum. 11(4). e0132923–e0132923. 11 indexed citations

García‐Fernández, Sergio, Daniel Pablo‐Marcos, Mónica Gozalo, et al.. (2022). Evaluation of the rapid antigen detection test STANDARD F COVID-19 Ag FIA for diagnosing SARS-CoV-2: experience from an Emergency Department. Diagnostic Microbiology and Infectious Disease. 103(2). 115683–115683. 6 indexed citations

Fernández-Martínez, Marta, et al.. (2022). In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides. Enfermedades Infecciosas y Microbiología Clínica. 41(9). 567–570.

Pablo‐Marcos, Daniel, et al.. (2021). Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19. Enfermedades Infecciosas y Microbiología Clínica. 41(3). 173–175. 1 indexed citations

10.

Pablo‐Marcos, Daniel, Ana Rodrı́guez, Mónica Gozalo, et al.. (2020). Description of Influenza B in seasonal epidemic in Cantabria during the beginning of the pandemia due to SARS-CoV-2. Revista Española de Quimioterapia. 33(6). 444–447. 1 indexed citations

11.

Pablo‐Marcos, Daniel, et al.. (2019). Primer caso descrito en España de infección por Wohlfahrtiimonas chitiniclastica. UCrea (University of Cantabria). 32(6). 558–560. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact